Urinary titanium and vanadium and breast cancer: A case-control study

Nutrition and Cancer

Volumn 64, Issue 3, 2012, Pages 368-376

  Tang, Lu Ying ^a   Su, Yi ^a   He, Jian Rong ^a   Chen, Wei Qing ^a   Su, Feng Xi ^a   Wu, Bang Hua ^b   Lin, Ying ^a   Ren, Ze Fang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b The Laboratory of Guangdong Testing Center of Occupational Hygiene   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TITANIUM; VANADIUM;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CASE CONTROL STUDY; CHINA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; URINALYSIS; URINE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; TITANIUM; TUMOR MARKERS, BIOLOGICAL; VANADIUM;

EID: 84859756526     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.654586     Document Type: Article

References (40)

1. Olszewski, U, Claffey, J, Hogan, M, Tacke, M, Zeillinger, R. 2011. Anticancer activity and mode of action of titanocene C. Invest New Drugs, 29: 607-614.
2. Barceloux, D G. 1999. Vanadium. J Toxicol Clin Toxicol, 37: 265-278. (Pubitemid 29292912)
3. Kopf-Maier, P, and, Hermann, G. 1984. Cytologic observations on the effects of metallocene dichlorides on human fibroblasts cultivated in vitro. Virchows Arch B Cell Pathol Incl Mol Pathol, 47: 107-122. (Pubitemid 14014239)
4. Fenech, M, and, Ferguson, L R. 2001. Vitamins/minerals and genomic stability in humans. Mutat Res, 475: 1-6. (Pubitemid 32280798)
5. Kostova, I. 2009. Titanium and vanadium complexes as anticancer agents. Anticancer Agents Med Chem, 9: 827-842.
6. Bishayee, A, Waghray, A, Patel, M A, and, Chatterjee, M. 2010. Vanadium in the detection, prevention and treatment of cancer: the in vivo evidence. Cancer Lett, 294: 1-12.
7. Kieler, J, Gromek, A, and, Nissen, N I. 1965. Studies on the antineoplastic effect of vanadium salts. Acta Chir Scand Suppl, 343: 154-164.
8. Kopf, H, and, Kopf-Maier, P. 1979. Titanocene dichloridethe first metallocene with cancerostatic activity. Angew Chem Int Ed Engl, 18: 477-478.
9. Ray, R S, Ghosh, B, Rana, A, and, Chatterjee, M. 2007. Suppression of cell proliferation, induction of apoptosis and cell cycle arrest: chemopreventive activity of vanadium in vivo and in vitro. Int J Cancer, 120: 13-23. (Pubitemid 44901912)
10. Korfel, A, Scheulen, M E, Schmoll, H J, Grundel, O, Harstrick, A. 1998. Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors. Clin Cancer Res, 4: 2701-2708. (Pubitemid 28523495)
11. Kroger, N, Kleeberg, U R, Mross, K, Edler, L, and, Hossfeld, D K. 2000. Phase II clinical trial of titanocene dichloride in patients with metastatic breast cancer. Onkologie, 23: 60-62. (Pubitemid 30154851)
12. Lummen, G, Sperling, H, Luboldt, H, Otto, T, and, Rubben, H. 1998. Phase II trial of titanocene dichloride in advanced renal-cell carcinoma. Cancer Chemother Pharmacol, 42: 415-417. (Pubitemid 28430373)
13. Somerville, J, and, Davies, B. 1962. Effect of vanadium on serum cholesterol. Am Heart J, 64: 54-56.
14. Nakasuji, K, Usuda, K, Kawasaki, T, Dote, E, Hayashi, S. 2006. Urinary and serum titanium: assessment as an indicator of exposure to ammonium citratoperoxotitanate (IV) and its influence on renal function. Biol Trace Elem Res, 110: 119-132.
15. Baran, E J. 2008. Vanadium detoxification: chemical and biochemical aspects. Chem Biodiversity, 5: 1475-1484.
16. Ren, Z, Cai, Q, Shu, X O, Cai, H, Cheng, J R. 2004. Genetic polymorphisms in the human growth hormone-1 gene (GH1) and the risk of breast carcinoma. Cancer, 101: 251-257. (Pubitemid 38890826)
17. He, J R, Tang, L Y, Yu, D D, Su, F X, Song, E W. 2011. Epstein-Barr virus and breast cancer: serological study in a high-incidence area of nasopharyngeal carcinoma. Cancer Lett, 309: 128-136.
18. Barr, D B, Wilder, L C, Caudill, S P, Gonzalez, A J, Needham, L L. 2005. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect, 113: 192-200. (Pubitemid 40326330)
19. Kopf-Maier, P, Wagner, W, and, Kopf, H. 1981. Different inhibition pattern of the nucleic acid metabolism after in vitro treatment with titanocene and vanadocene dichlorides. Naturwissenschaften, 68: 272-273. (Pubitemid 11082159)
20. Ghosh, P, DCruz, O J, Narla, R K, and, Uckun, F M. 2000. Apoptosis-inducing vanadocene compounds against human testicular cancer. Clin Cancer Res, 6: 1536-1545. (Pubitemid 30226244)
21. Ray, R S, Roy, S, Samanta, S, Maitra, D, and, Chatterjee, M. 2005. Protective role of vanadium on the early process of rat mammary carcinogenesis by influencing expression of metallothionein, GGT-positive foci and DNA fragmentation. Cell Biochem Funct, 23: 447-456. (Pubitemid 41640425)
22. Ray, R S, Basu, M, Ghosh, B, Samanta, K, and, Chatterjee, M. 2005. Vanadium, a versatile biochemical effector in chemical rat mammary carcinogenesis. Nutr Cancer, 51: 184-196. (Pubitemid 40734719)
23. Ray, R S, Rana, B, Swami, B, Venu, V, and, Chatterjee, M. 2006. Vanadium mediated apoptosis and cell cycle arrest in MCF7 cell line. Chem Biol Interact, 163: 239-247. (Pubitemid 44572229)
24. Caruso, F, and, Rossi, M. 2004. Antitumor titanium compounds. Mini Rev Med Chem, 4: 49-60. (Pubitemid 38842594)
25. Moasser, M M. 2007. The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene, 26: 6469-6487. (Pubitemid 47530601)
26. Koch, H M, and, Calafat, A M. 2009. Human body burdens of chemicals used in plas- tic manufacture. Philos Trans R Soc Lond B Biol Sci, 364: 2063-2078.
27. Perry, H M Jr., and, Perry, E F. 1959. Normal concentrations of some trace metals in human urine: changes produced by ethylenediaminetetraacetate. J Clin Invest, 38: 1452-1463.
28. Yin, Y, Zhang, T, Dai, Y, Zheng, X, Pei, L. 2009. Pilot study of association of anembryonic pregnancy with 55 elements in the urine, and serum level of folate, homocysteine and s-adenosylhomocysteine in Shanxi Province, China. J Am Coll Nutr, 28: 50-55.
29. Stanek, E J III, Calabrese, E, Barnes, R M, Keegan, E, Lasztity, A. 1988. Ingestion of trace elements from food among preschool children: Al, Ba, Mn, Si, Ti, V, Y, and Zr. J Trace Elem Exp, 1: 179-190. (Pubitemid 19104837)
30. Tyler, G. 2004. Ionic charge, radius, and potential control root/soil concentration ratios of fifty cationic elements in the organic horizon of a beech (Fagus sylvatica) forest podzol. Sci Total Environ, 329: 231-239. (Pubitemid 38950568)
31. Evangelou, A M. 2002. Vanadium in cancer treatment. Crit Rev Oncol Hematol, 42: 249-265. (Pubitemid 34615688)
32. Setyawati, I A, Thompson, K H, Yuen, V G, Sun, Y, Battell, M. 1998. Kinetic analysis and comparison of uptake, distribution, and excretion of 48V-labeled compounds in rats. J Appl Physiol, 84: 569-575. (Pubitemid 28081110)
33. Edel, J, and, Sabbioni, E. 1988. Retention of intratracheally instilled and ingested tetravalent and pentavalent vanadium in the rat. J Trace Elem Electrolytes Health Dis, 2: 23-30.
34. Thomas, R G, and, Archuleta, R F. 1980. Titanium retention in mice. Toxicol Lett, 6: 115-118. (Pubitemid 10017789)
35. Coen, N, Kadhim, M A, Wright, E G, Case, C P, and, Mothersill, C E. 2003. Particulate debris from a titanium metal prosthesis induces genomic instability in primary human fibroblast cells. Br J Cancer, 88: 548-552. (Pubitemid 36367203)
36. Gaudet, M M, Falk, R T, Gierach, G L, Lacey, J V Jr., Graubard, B I. 2010. Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?. Cancer Epidemiol, 34: 580-586.
37. Jordan, S, Lim, L, Vilainerun, D, Banks, E, Sripaiboonkij, N. 2009. Breast cancer in the Thai Cohort Study: an exploratory case-control analysis. Breast, 18: 299-303.
38. Kawai, M, Minami, Y, Kuriyama, S, Kakizaki, M, Kakugawa, Y. 2010. Reproductive factors, exogenous female hormone use and breast cancer risk in Japanese: the Miyagi Cohort Study. Cancer Causes Control, 21: 135-145.
39. Spencer, E, Key, T, Appleby, P, van Gils, C, Olsen, A. 2009. Prospective study of the association between grapefruit intake and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control, 20: 803-809.
40. Needham, L L, Calafat, A M, and, Barr, D B. 2007. Uses and issues of biomonitoring. Int J Hyg Environ Health, 210: 229-238. (Pubitemid 46629158)